Category: Press Releases

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More

Adrian Ridge nomeado CEO do Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Califórnia, July 02, 2024 (GLOBE NEWSWIRE) — A partir de 1 de julho de 2024, Adrian Ridge é o CEO do Nikkiso Clean Energy & Industrial Gases Group, parte da divisão industrial da Nikkiso Co. Ltd. Ridge sucede a Peter Wagner, que continua a desempenhar funções no Conselho de Administração como Executive Chairman do […]

Read More

Global Citizen Award 2024 : lancement de l’appel à candidatures

LONDRES, 02 juill. 2024 (GLOBE NEWSWIRE) — En partenariat avec la fondation humanitaire suisse à but non lucratif Andan Foundation, le cabinet de conseil de premier plan en résidence et en citoyenneté internationales, Henley & Partners, a le plaisir d’annoncer le lancement de l’appel à candidatures pour le Global Citizen Award 2024. Créé il y a dix ans, en […]

Read More